Related Experiment Video

Updated: May 17, 2026

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
14:57

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

Published on: October 10, 2020

Glutathione S-transferase P1-1 as a target for mesothelioma treatment

Anastasia De Luca1, Francesca Pellizzari Tregno, Andrea Sau

  • 1Department of Chemical Sciences and Technologies, University of Tor Vergata, Rome, Italy.

Cancer Science
|November 6, 2012
PubMed

Insights

NBDHEX effectively targets mesothelioma cells by inhibiting glutathione-S-transferase. This novel drug shows promise as a potent treatment, alone or with cisplatin, for this rare cancer.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Malignant pleural mesothelioma is a rare and aggressive cancer.
  • The tumor overexpresses glutathione-S-transferase, an enzyme involved in drug resistance.
  • Platinum-based chemotherapy efficacy is limited by glutathione-S-transferase activity.

Purpose of the Study:

  • To evaluate the efficacy of NBDHEX, a glutathione-S-transferase inhibitor, against human mesothelioma cell lines.
  • To investigate the molecular mechanisms of NBDHEX action.
  • To assess the potential of NBDHEX as a therapeutic agent for malignant pleural mesothelioma.

Main Methods:

  • Treatment of mesothelioma cell lines (MSTO-211H, MPP89, MM-B1, Mero 48a) with NBDHEX.
  • Assessment of cell viability and apoptosis induction.
  • Analysis of JNK, p38, and caspase activation.
  • Evaluation of oxidative stress markers.
  • Combination studies with cisplatin.

Main Results:

  • NBDHEX demonstrated significant efficacy across all tested mesothelioma cell lines, with IC(50) values in the low micromolar range (1-4 μM).
  • The drug induced apoptosis via sustained activation of JNK and p38 pathways.
  • NBDHEX caused oxidative stress in specific cell lines (MPP89, MM-B1).
  • Efficacy was comparable or superior to cisplatin, with synergistic or additive effects when combined.

Conclusions:

  • NBDHEX is a potent inhibitor of mesothelioma cell growth.
  • It represents a promising therapeutic strategy, either as a single agent or in combination with cisplatin.
  • Further investigation into NBDHEX for malignant pleural mesothelioma treatment is warranted.

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Related Concept Videos

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...